2024-11-28 00:33:03
KAZIA TO PRESENT FINAL DATA FROM PAXALISIB PHASE II STUDY IN GLIOBLASTOMA AT ESMO
Corporate/ 2023-07-24
KAZIA TO PRESENT FINAL DATA FROM PAXALIS...

SYDNEY,Sept. 9,2022--Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA),an oncology-focused drug development company,today announced that f...

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism
Health/ 2023-07-22
TRANSFORM 1 Enrollment Completed: A Cruc...

BIRMINGHAM,England,Sept. 13,2022--Concept Medicalannounces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary ves...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release